SAN DIEGO, April 12, 2016 — Introduced by Sen. Mark Kirk, R-Ill., in collaboration with Sens. Susan Collins, R-Me., and Joe Manchin, D-W.V., the Regrow Act became an amendment in the Food and Drug Administration and National Institutes of Health Workforce Authorities Modernization Act (S.2700), which was recently passed unanimously by the Senate Committee on Health, Education, Labor and Pension.
The addition of the REGROW Act to S.2700 has the potential to help propel modernization of the FDA’s current regulatory approaches toward safe and effective cell therapies, while advancing regenerative medicine in general.
According to Kirk, “Creating FDA standards will ensure access to new life-saving treatments and prevent the U.S. from falling further behind other nations in the field.”
Janet Marchiobroda, health innovation director for the Bipartisan Policy Center, said, “This legislation will also help translate scientific discovery into new treatments and therapies for patients.”
With an ever-increasing aging population, and the unprecedented growth of the baby boomer generation, S.2700 promises to dramatically improve quality of life while also finding possible cures for those suffering from some of the most devastating and pervasive diseases of our time.
Additionally, reducing the need for chronic care through research, innovation and partnership will help lower the high escalating costs of health care in America.
In additional to providing increased salaries for those with the necessary scientific expertise to move S.2700 forward, leveraging development while increasing availability of research data will be instrumental in enabling greater understanding of disease processes and how they may be cured.
Speeding up the approval process for clinical trials, development of medical devices and creation of new pharmaceuticals will provide quicker and better access to those in need.
The addition of the REGROW Act as an amendment to S.2700 promises “to restore healthy organ and tissue function (and) represents one of the most promising areas for the next generation of groundbreaking treatments,” according to www.bipartisanpolicy.org.
In a recent press release from Kirk’s office, a report from the U.S. Government Accountability Office indicated that “virtually any disease that results from malfunctioning, damaged or failing tissues may be potentially cured through regenerative medicine treatments.”
A world with dramatically lower levels of human suffering and significantly improved quality of life for millions of people worldwide is a possibility whose time has come.
Aging will become less a stigma of decrepitude and suffering and much more a promise of the privilege of a longer and more enjoyable life full of greater opportunities for contributing time and talent and to make a positive difference.
Until next time, enjoy the ride in good health!
Laurie Edwards-Tate, MS, is a health care provider of over 32 years. As a featured “Communities Digital News” columnist, LifeCycles with Laurie Edwards-Tate emphasizes healthy aging and maintaining independence, while delighting and informing its readers. Laurie is a recognized expert in home and community-based, long-term care services, and is also an educator.
In addition to writing for “Communities Digital News,” Laurie is the President and CEO of her firm, At Your Home Familycare, which serves persons of all ages who are disabled and infirm with a variety of non-medical, in-home care and concierge services.
Copyright © 2016 by At Your Home Familycare